Wound Management Technologies Market Cap 2014-2020 | SMTI

Wound Management Technologies market cap history and chart from 2014 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Wound Management Technologies market cap as of July 10, 2020 is $0.12B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.117B $0.012B
Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $164.573B 28.54
Medtronic (MDT) Ireland $121.803B 19.78
Stryker (SYK) United States $66.678B 21.64
Boston Scientific (BSX) United States $48.529B 22.82
Baxter (BAX) United States $43.229B 0.00
Lonza Group Ag (LZAGY) Switzerland $42.790B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $29.034B 0.00
Terumo (TRUMY) Japan $28.019B 35.82
ResMed (RMD) United States $27.789B 43.86
Zimmer Biomet Holdings (ZBH) United States $24.651B 15.51
Sunny Optical Technology (SNPTF) China $19.798B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.859B 0.00
Bio-Rad Laboratories (BIO) United States $14.161B 64.46
Shandong Weigao Medical Polymer (SHWGF) China $13.702B 0.00
Insulet (PODD) United States $13.110B 1298.88
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $10.359B 81.40
GN STORE NORD (GNNDY) Denmark $7.527B 38.37
Perrigo (PRGO) Ireland $7.520B 13.46
Hill-Rom Holdings (HRC) United States $7.384B 20.82
William Demant Holdings (WILYY) Denmark $6.296B 0.00
Canopy Growth (CGC) Canada $6.112B 0.00
Haemonetics (HAE) United States $4.436B 26.64
Neogen (NEOG) United States $4.094B 69.35
GW Pharmaceuticals (GWPH) United Kingdom $3.971B 0.00
ICU Medical (ICUI) United States $3.820B 27.86
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.796B 0.00
Agios Pharmaceuticals (AGIO) United States $3.644B 0.00
Abcam (ABCZY) $3.447B 0.00
Envista Holdings (NVST) United States $3.215B 0.00
NuVasive (NUVA) United States $2.805B 22.52
TG Therapeutics (TGTX) United States $2.618B 0.00
National Vision Holdings (EYE) United States $2.314B 40.03
AtriCure (ATRC) United States $1.753B 0.00
MacroGenics (MGNX) United States $1.500B 0.00
Aurora Cannabis (ACB) Canada $1.361B 0.00
NanoString Technologies (NSTG) United States $1.319B 0.00
Aphria (APHA) Canada $1.238B 0.00
Cerus (CERS) United States $1.120B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.112B 0.00
Cardiovascular Systems (CSII) United States $1.032B 0.00
Meridian Bioscience (VIVO) United States $1.025B 38.60
Phibro Animal Health (PAHC) United States $1.015B 20.24
PetIQ (PETQ) United States $0.992B 28.64
Vapotherm (VAPO) United States $0.983B 0.00
Zynex (ZYXI) United States $0.949B 95.27
OraSure Technologies (OSUR) United States $0.833B 167.81
InMode (INMD) Israel $0.826B 17.45
Quanterix (QTRX) United States $0.772B 0.00
Omeros (OMER) United States $0.742B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.663B 47.50
BioLife Solutions (BLFS) United States $0.620B 176.54
VAREX IMAGING (VREX) United States $0.586B 14.54
Lantheus Holdings (LNTH) United States $0.573B 11.54
Surmodics (SRDX) United States $0.570B 68.62
LeMaitre Vascular (LMAT) United States $0.519B 29.58
Owens & Minor (OMI) United States $0.459B 12.13
Viemed Healthcare (VMD) United States $0.408B 36.17
Cytosorbents (CTSO) United States $0.367B 0.00
HEXO (HEXO) $0.334B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.330B 0.00
Utah Medical Products (UTMD) United States $0.302B 21.93
Organigram Holdings (OGI) Canada $0.269B 0.00
Female Health (VERU) United States $0.208B 0.00
Chimerix (CMRX) United States $0.190B 0.00
Surface Oncology (SURF) United States $0.163B 0.00
Bovie Medical (APYX) United States $0.163B 0.00
Fonar (FONR) United States $0.136B 12.09
Exagen (XGN) United States $0.134B 0.00
Liberty Health Sciences (LHSIF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.115B 0.00
Evolus (EOLS) United States $0.108B 0.00
MTech Acquisition (KERN) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.078B 0.00
Nephros (NEPH) United States $0.066B 0.00
United-Guardian (UG) United States $0.066B 15.32
Trinity Biotech (TRIB) Ireland $0.064B 0.00
Capricor Therapeutics (CAPR) United States $0.062B 0.00
Brainsway (BWAY) Israel $0.060B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
FSD PHARMA INC (HUGE) Canada $0.033B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
Senestech (SNES) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00